Labcorp Holdings (LH) EPS (Weighted Average and Diluted) (2009 - 2026)

Labcorp Holdings has disclosed EPS (Weighted Average and Diluted) across 18 years of filings, most recently posting $3.35 for Q1 2026.

• EPS (Weighted Average and Diluted) for Q1 2026 came in at $3.35, up 32.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.29 (up 30.37% YoY), and the FY2025 annual result was $10.46, up 18.33% from the prior year.
• EPS (Weighted Average and Diluted) came in at $3.35 for Q1 2026 at Labcorp Holdings, up from $1.98 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $5.23 in Q1 2022 to a low of -$2.3 in Q4 2023.
• The 5-year median for EPS (Weighted Average and Diluted) is $2.43 (2024), against an average of $2.33.
• Across the five-year window, EPS (Weighted Average and Diluted) sank 342.11% in 2023 and surged 174.35% in 2024, its largest moves.
• Labcorp Holdings' EPS (Weighted Average and Diluted) stood at $0.95 in 2022, then slumped by 342.11% to -$2.3 in 2023, then soared by 174.35% to $1.71 in 2024, then increased by 15.79% to $1.98 in 2025, then jumped by 69.19% to $3.35 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $3.35 (Q1 2026), $1.98 (Q4 2025), and $3.12 (Q3 2025), per Business Quant data.